Drug recall · August 29, 2018
Diltiazem HCl Extended-release Capsules recall
Why: Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08
- Lots / codes
Batch 3096049
- Quantity
- 408 cartons
- Company
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL
- Distribution
- Nationwide USA
- Initiated
- August 14, 2018 · Voluntary: Firm initiated
- Classified
- August 22, 2018
- Reported
- August 29, 2018
- Ended
- June 26, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diltiazem
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.